Group 1: Shanghai International Economic Center Development - The successful launch of China's first domestic segmented production pilot project for biological products [2] - Initiation of a pilot program for expanding value-added telecommunications services to attract foreign investment [2] - Establishment of a digital and standardized transformation in the domestic reinsurance industry to enhance global risk governance capabilities [2] Group 2: Shanghai International Trade Center Development - Implementation of a "white list" management innovation for the inspection of imported consumer goods to streamline customs clearance for new products [4] - Development of an international data center in the Lingang New Area to promote data openness and international cooperation in digital trade [4] - Creation of a low-carbon energy refueling center for ships, positioning Shanghai as one of the few ports capable of LNG and green methanol refueling [4] Group 3: Shanghai International Technology Innovation Center Development - Establishment of a "basic research pilot zone" to enhance Shanghai's technological innovation capabilities [5] - Development of a synthetic biology innovation center to create a globally influential technology and industry hub [5] - Introduction of innovation vouchers that shift the approach from "finding policies from enterprises" to "policies finding enterprises," stimulating innovation and entrepreneurship [5]

12月7日，上海市加快推进"五个中心"建设领导小组办公室聚焦具有首创性、引领性的重大改革事项和政策创新试点，遴选发布了2025年上海"五个中心"建 设典型实践案例。 离岸贸易跨一线结算免审单据,实现对 的跨境结算效率,提升企业便利度和获得 上海国际贸易中心建设 成功推进全国首个境内生物制品分段生 产试点项目落地。 在全国率先启动增值电信业务扩大对 试点,吸引外资企业来华开展业务。 打造上海国际再保险 登记交易中心 推动国内再保险行业在全球率先实现数 字化、标准化转型,提升参与全球风险 治理能力。 开展临港离岸贸易金融服务 综合改革试点 率先试点首发 进口消费品检验便利化措施 实施"企业+产品"白名单管理创新,破解进 口首发新品通关痛点堵点。 创新建设 临港新片区国际数据中心 促进数据领域对外开放与国际合作、创 数字贸易。 打造国际船舶 水水中转"一箱制" 低碳能源加注中心 助力运输降本提质增效 发展船舶低碳燃料加注,成为全球少数同 通过开展水水中转"一箱制"运输模式, 时具备LNG与绿色甲醇加注能力的港口。 报流程、减少审批周期。 官海国际科技创新中心建设 创设"基础研究先行区" 遵循基础研究规律和人才成长规 ...

Core Insights - The seminar held in Shanghai on December 7 focused on accelerating the construction of the "Five Centers" during the 14th Five-Year Plan period, addressing new opportunities and challenges arising from significant changes in domestic and international development [1] Group 1: Innovation in Biopharmaceuticals - Shanghai has initiated a pilot project for segmented production of biopharmaceuticals, successfully launching the first domestic project for innovative drug production, attracting an investment of 3.14 billion yuan from Roche and other companies [2] - The segmented production model has been incorporated into local regulations, enhancing the efficiency of biopharmaceutical resource allocation [2] Group 2: Telecommunications and Digital Services - Shanghai has become the first in the country to pilot the expansion of value-added telecommunications services, allowing foreign companies to operate independently in specific zones, with nine foreign enterprises currently participating [2] - This initiative aims to deepen foreign investment in digital services, including cloud computing and data processing [2] Group 3: Artificial Intelligence Development - The establishment of a large-scale humanoid robot training ground aims to transition embodied intelligence from research to practical applications, achieving a model transfer success rate of over 95% [3] - This initiative supports various sectors, including smart manufacturing and public services, enhancing robots' capabilities in complex environments [3] Group 4: International Financial Center - The Shanghai International Reinsurance Registration and Trading Center has achieved a digital and standardized transformation, with 131 institutions registered and a trading premium of 5.3 billion yuan recorded in the first ten months of 2025 [4] - A pilot reform for offshore trade finance services has been launched, significantly improving cross-border settlement efficiency for offshore trade enterprises [4] Group 5: Technology Innovation and Support - The introduction of a growth tier in the Sci-Tech Innovation Board aims to support technology companies with significant breakthroughs but currently unprofitable, with a total market value of nearly 1.3 trillion yuan for 35 listed companies [5] - The Shanghai government has implemented a "no application required" policy for technology innovation vouchers, benefiting over 30,000 small and medium-sized tech enterprises and increasing voucher orders by 60% from September to November [12] Group 6: International Trade and Data Economy - Shanghai has piloted measures for the facilitation of imported consumer goods inspections, resulting in 1,040 entries and 2,940 batches benefiting from these measures by September 2025 [7] - The construction of an international data center aims to promote data openness and cooperation, establishing a data economy industrial system that supports cross-border data flow [8] Group 7: Shipping and Maritime Innovation - Shanghai has developed a low-carbon fuel supply system for ships, becoming one of the few ports globally capable of supplying both LNG and green methanol, with 1.45 million cubic meters of LNG supplied to 251 vessels by October 2025 [9] - The implementation of a "one-box" water-to-water transfer model has significantly improved logistics efficiency in the Yangtze River Delta region, with increases in cargo declaration numbers and operational efficiency exceeding 30% [9]

Industry Overview - The chemical sector's overall performance ranked 13th this week (2025/11/24-2025/11/28) with a change of 2.98%, positioned in the upper-middle of the market. The Shanghai Composite Index rose by 1.40%, while the ChiNext Index increased by 4.54%. The Shenwan Chemical sector outperformed the Shanghai Composite by 1.58 percentage points but underperformed the ChiNext by 1.56 percentage points [1]. Key Insights - The chemical industry is expected to continue its trend of divergence in 2025, with recommendations to focus on synthetic biology, pesticides, chromatography media, sweeteners, vitamins, light hydrocarbon chemicals, COC polymers, and MDI [1]. Synthetic Biology - A pivotal moment for synthetic biology is anticipated, driven by energy structure adjustments. Traditional chemical companies will face competition based on energy consumption and carbon tax costs. Companies that adopt green energy alternatives and leverage integrated and scaled advantages are likely to reduce energy costs and expand into larger overseas markets. The demand for bio-based materials is expected to surge, leading to potential profitability and valuation increases. Key companies to watch include Kasei Bio and Huaheng Bio [1]. Refrigerants - The implementation of quota policies is expected to usher in a high-growth cycle for third-generation refrigerants. Starting in 2024, the supply of these refrigerants will enter a "quota + continuous reduction" phase, while second-generation refrigerants will be phased out more rapidly. The demand for refrigerants is projected to grow steadily due to the development of heat pumps, cold chain markets, and the expansion of the air conditioning market in Southeast Asia. Companies with high quota shares, such as Juhua Co., Sanmei Co., Haohua Technology, and Yonghe Co., are expected to benefit significantly [2]. Electronic Specialty Gases - Electronic specialty gases are critical to the electronics industry and represent a core component of domestic industrialization. The domestic market is experiencing rapid upgrades in wafer manufacturing, but there is a mismatch with the fragmented and insufficient capacity of high-end electronic specialty gases. Companies that establish high-end capacity and possess substantial technical reserves are likely to seize opportunities for growth. Demand is driven by integrated circuits, displays, and photovoltaics. Key players include Jinhong Gas, Huate Gas, and China Shipbuilding Gas [3]. Light Hydrocarbon Chemicals - The trend towards light raw materials in the global olefin industry has been significant over the past decade, with a shift from heavy naphtha to lighter low-carbon alkanes like ethane and propane. This transition is characterized by shorter processes, higher yields, and lower costs. Light hydrocarbon chemicals also align with global low-carbon and energy-saving initiatives. Companies in this sector, such as Satellite Chemical, are expected to see their values reassessed [4]. COC Polymers - The industrialization of COC/COP (cyclic olefin copolymer) is accelerating in China, driven by domestic companies achieving breakthroughs after years of R&D. The shift of downstream industries, such as consumer electronics and new energy vehicles, to domestic sources is increasing the demand for these materials. The market is currently constrained by high prices, but domestic companies are expected to break through and expand market space. Key company to watch is Acolyte [5]. Potash Fertilizers - Potash fertilizer prices are expected to rebound as the industry enters a destocking cycle. Canpotex has withdrawn new quotes, and Nutrien has announced production cuts, leading to a short-term decline in supply. The termination of the Black Sea Grain Export Agreement has increased the prices of wheat and corn, boosting the demand for potash fertilizers. Companies like Yara International, Salt Lake Potash, and Zangge Mining are positioned to benefit from this trend [6]. MDI Market - The MDI market is characterized by oligopoly, with demand steadily improving due to the expansion of polyurethane applications. The global MDI production capacity is concentrated among five major chemical giants, which account for 90.85% of total capacity. Despite current price fluctuations, MDI remains a high-margin product. Companies like Wanhua Chemical are expected to benefit from a favorable supply structure as demand recovers [7]. Price Tracking - The top five price increases this week included methanol (East China) at 6.27%, NYMEX natural gas (futures) at 5.90%, and caprolactam (East China CPL) at 5.49%. The top five price decreases included liquid chlorine (East China) at -7.82% and propylene oxide (East China) at -5.85% [8]. Supply Side Tracking - This week, 168 chemical enterprises had their production capacities affected, with 9 new repairs and 3 restarts reported [9].

Core Viewpoint - The concept of "patience" in investment is not merely about long-term holding but involves understanding industrial and economic development patterns, serving as a partner to entrepreneurs to navigate economic cycles together [2][3]. Investment Philosophy - Shunchuang Chantuo emphasizes "patient capital" in its investment philosophy, which is rooted in a deep understanding of industry and economic trends, and aims to support entrepreneurs through various economic cycles [3][6]. Investment Strategy and Performance - Since its establishment in January 2023, Shunchuang Chantuo has launched 12 funds with a total scale exceeding 4 billion yuan, focusing on hard technology sectors such as autonomous driving, high-end manufacturing, and synthetic biology [3]. - The firm has invested in innovative technology companies like Zhuxian Technology and Zhongke Hongtai, which possess core innovation capabilities [3]. Role as a Service Provider - Shunchuang Chantuo positions itself as a service provider rather than just an investor, addressing the specific pain points and real demands of portfolio companies by offering strategic guidance, management consulting, and resource integration [6][9]. - For instance, in its management of Zhuxian Technology, the firm has facilitated connections with key potential clients in the logistics sector and supported the company in navigating market strategies [9]. Focus on Micro-Innovation - The firm believes that true innovation does not always come from revolutionary technologies but often from stable, reliable, and cost-effective solutions that can be quickly applied in real-world scenarios [12][13]. - Companies like Zhongke Hongtai and Juyuan Robotics exemplify this approach, achieving breakthroughs in cost-effective production methods and automation in challenging work environments [14][15]. Diverse Perspectives in Investment Decisions - Shunchuang Chantuo benefits from a diverse LP structure, which includes financial institutions and industrial enterprises, providing a multifaceted perspective on risk control and industry judgment [17]. - The firm employs a fund segmentation strategy to balance the diverse demands of its LPs, ensuring clarity and efficiency in investment decisions [17]. Definition of Investment Success - Success is not solely defined by financial returns but also by the validation of economic cycles, industry, and founder judgments, which reflect the team's commitment to the "patient capital" philosophy [18][19].

Group 1: Financing Overview - The technology and manufacturing sectors saw over 30 financing cases and multiple transactions exceeding 100 million RMB, with significant investments in AI, semiconductors, and commercial aerospace [1] - A total of 36 financing events occurred in the domestic primary market from November 17 to November 23, with 31 disclosing amounts totaling approximately 4.55 billion RMB [1] Group 2: Sector-Specific Financing - The advanced manufacturing sector led with 10 financing cases totaling about 1.05 billion RMB, followed by the biomedicine sector with 7 cases at approximately 750 million RMB, and the artificial intelligence sector with 4 cases totaling around 760 million RMB [3] - The medical health sector showed robust activity with significant transactions, including 500 million RMB for Repu Morning and 60 million USD for Tuoji Medicine, focusing on regenerative medicine and innovative medical devices [1][24] Group 3: Regional Financing Distribution - The financing activities were primarily concentrated in Zhejiang, Shanghai, and Jiangsu provinces, with 9, 8, and 7 cases respectively [5] Group 4: Active Investment Institutions - Qiming Venture Partners and Sequoia China were notably active, with Qiming completing 4 financing cases and Sequoia completing 3, mainly in technology and healthcare sectors [8] Group 5: Notable Company Financing - Star Motion Era secured nearly 1 billion RMB in A+ round financing, led by Geely Capital, focusing on humanoid robot development [39] - Repu Morning achieved 500 million RMB in A+ round financing, emphasizing its disruptive regenerative medicine technology [24] - Mingche Bio completed several million RMB in A round financing, specializing in ophthalmic medical devices [13]

Investment Rating - The industry investment rating is "Overweight" [1] Core Views - The chemical sector overall experienced a decline of 7.47% during the week of November 17-21, 2025, ranking 29th among all sectors, underperforming the Shanghai Composite Index by 3.57 percentage points [4][22] - The report highlights a continued trend of divergence in the chemical industry for 2025, recommending focus on sectors such as synthetic biology, pesticides, chromatography media, sweeteners, vitamins, light hydrocarbon chemicals, COC polymers, and MDI [4] Summary by Sections Industry Performance - The chemical sector's performance was notably poor, with the Shanghai Composite Index declining by 3.90% and the ChiNext Index by 6.15% during the same period [4][22] - The report indicates that the chemical sub-sectors showed varied performance, with the least decline in refining chemicals (-0.58%) and the most significant decline in fluorinated chemicals (-11.00%) [23] Key Industry Dynamics - The report discusses the upcoming quota policies for refrigerants, which are expected to enter a high prosperity cycle starting in 2024, with a continuous reduction in supply for second-generation refrigerants [5] - The electronic specialty gases market is highlighted as a critical area for domestic substitution opportunities due to high technical barriers and increasing demand from semiconductor and photovoltaic sectors [6][8] - The light hydrocarbon chemical trend is identified as a global movement, with a shift towards lighter raw materials for olefin production, which is expected to enhance the valuation of leading companies in this sector [8] - The COC polymer industry is experiencing accelerated domestic industrialization, driven by the shift of downstream industries to domestic production and the need for supply chain security [9] - The potassium fertilizer market is anticipated to rebound as major producers reduce output, leading to a potential recovery in prices [10] - The MDI market is characterized by oligopoly, with a favorable supply structure expected as demand gradually recovers [12]

Industry Overview - The chemical sector's overall performance ranked 9th this week (2025/11/10-2025/11/14) with a change of 2.61%, outperforming the Shanghai Composite Index by 2.79 percentage points and the ChiNext Index by 5.62 percentage points [1] - The chemical industry is expected to continue its differentiated trend in 2025, with a focus on synthetic biology, pesticides, chromatography media, sweeteners, vitamins, light hydrocarbon chemicals, COC polymers, and MDI [1] Synthetic Biology - The arrival of a pivotal moment in synthetic biology is anticipated, driven by the adjustment of energy structures, which may disrupt fossil-based materials and favor low-energy products [1] - Traditional chemical companies are expected to compete on energy consumption and carbon tax costs, with successful firms leveraging green energy and integrated advantages to reduce costs [1] - The demand for bio-based materials is projected to surge, leading to potential profitability and valuation increases for companies in this sector, such as Kasei Bio and Huaheng Bio [1] Refrigerants - The implementation of quota policies is expected to usher in a high-growth cycle for third-generation refrigerants, with supply entering a "quota + continuous reduction" phase starting in 2024 [2] - The demand for refrigerants is anticipated to grow due to the development of heat pumps, cold chain markets, and the expansion of the air conditioning market, particularly in Southeast Asia [2] - Companies with a high quota share, such as Juhua Co., Sanmei Co., Haohua Technology, and Yonghe Co., are expected to benefit significantly [2] Electronic Specialty Gases - Electronic specialty gases are critical to the electronics industry, characterized by high technical barriers and added value [3] - The domestic market faces a mismatch between rapid upgrades in wafer manufacturing and insufficient high-end electronic specialty gas capacity, presenting opportunities for domestic replacements [3] - Companies like Jinhong Gas, Huate Gas, and China Shipbuilding Gas are positioned to capitalize on this demand [3] Light Hydrocarbon Chemicals - The trend towards light raw materials in the global olefin industry is becoming more pronounced, with a shift from heavy naphtha to lighter low-carbon alkanes like ethane and propane [4] - Light hydrocarbon chemicals are favored for their low carbon emissions, low energy consumption, and low water usage, aligning with global carbon neutrality goals [4] - Companies in the light hydrocarbon sector, such as Satellite Chemical, are expected to see a revaluation of their worth [4] COC Polymers - The industrialization of COC/COP (cyclic olefin copolymer) is accelerating in China, driven by domestic companies overcoming previous R&D challenges [5] - The shift of downstream industries like consumer electronics and new energy vehicles to domestic production is enhancing the demand for COC/COP materials [5] - Companies like Acolyte are recommended for their potential in the COC polymer production segment [5] Potash Fertilizers - Potash fertilizer prices are expected to rebound as the industry enters a destocking cycle, with supply reductions from major players like Canpotex and Nutrien [6] - The termination of the Black Sea Grain Export Agreement has led to increased prices for wheat and corn, boosting the demand for potash fertilizers [6] - Companies such as Yara International, Salt Lake Potash, and Zangge Mining are highlighted as key players in this sector [6] MDI Market - The MDI market is characterized by oligopoly, with demand steadily increasing due to the expansion of polyurethane applications [7] - Major global manufacturers, including Wanhua Chemical, BASF, Covestro, Huntsman, and Dow, control over 90% of MDI production capacity [7] - Despite current price pressures, MDI is expected to maintain profitability, with a positive outlook as demand recovers [7] Chemical Price Tracking - The top five price increases this week included dimethylcyclosiloxane (DMC) at 18.18%, sulfur at 8.96%, and NYMEX natural gas at 5.82% [8] - The top five price decreases included butadiene at -7.89% and hydrofluoric acid at -4.27% [8] Supply Side Tracking - This week, 164 chemical enterprises reported production capacity changes, with 11 new repairs and 5 restarts noted [9]

Group 1 - The article emphasizes the strategic importance of biological manufacturing as a key industry for future development, highlighted by its inclusion in the 15th Five-Year Plan alongside quantum technology and 6G [2] - The upcoming "SynBio China Fourth Synthetic Biology and Biomanufacturing Conference" will take place in Shenzhen on January 8-9, 2026, focusing on industrialization technology challenges and providing comprehensive solutions for intelligent manufacturing and green production [3][2] - The conference aims to gather experts from academia and industry to analyze the entire process of "design-build-test-learn" in synthetic biology, addressing the optimization and innovation opportunities in various industrialization stages [2] Group 2 - The conference is expected to host around 1,000 participants, indicating significant interest and engagement in the field of synthetic biology and biomanufacturing [3] - There are opportunities for exhibitors from synthetic biology and modern biotechnology sectors to showcase their products and technologies at the conference [9] - Registration for the conference is currently free but limited, emphasizing the need for early registration to secure participation [12]

Core Insights - The article highlights the upcoming "SynBio China Fourth China Synthetic Biology and Biomanufacturing Conference" scheduled for January 8-9, 2026, in Shenzhen, emphasizing the importance of biomanufacturing in future industries [4][8]. Group 1: Conference Details - The conference will feature Dr. Zhang Dongyuan, Chairman of Zhongke Kangyuan (Tangshan) Biotechnology Co., Ltd., who will present a report on the key technologies for the depolymerization of non-grain biomass [2][4]. - The event aims to gather 1,000 participants from various sectors, including academia and industry, to address challenges in industrialization technology [8]. Group 2: Background and Significance - The conference is positioned within the context of China's strategic focus on biomanufacturing as a critical area for future development, alongside quantum technology and 6G [7]. - The article discusses the challenges of crossing the "valley of death" in biomanufacturing, highlighting opportunities for optimization and innovation in various industrialization processes [7]. Group 3: Technological Innovations - Zhongke Kangyuan has developed a comprehensive technology system for biomass depolymerization over seven years, including key technologies such as a continuous oxidation depolymerization system and a high-solid continuous fermentation system [4]. - The company has successfully established China's first production line capable of processing 200,000 tons of straw protein and digestible sugars [4].